Contact Person : Marilyn B. Turner; Last Date for the submission of abstract : 08-Jan-2019; Raw material requirements in a cGMP environment are often overlooked as a Company develops new products. Depending upon the product being developed, e.g., tablets and capsules vs. biotechnology products to include recombinant microorganisms and gene therapy products, as few as fteen to twenty.